Recruiting
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
NCT07563699
- Conditions
- Diabete Type 2, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Mapi pharma Investigational Site ISR001 Tel Aviv, Israel